论文信息 - Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial - 字舞流文

Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial

S. Leung | T. Nielsen | E. S. Stovgaard | A. Laenkholm | M. Jensen | D. Gao | B. Ejlertsen | N. Riaz | Karama Asleh | Elahe Shenasa | E. Stovgaard | E. Shenasa